Stifel Financial’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,694
Closed -$78.9K 3470
2024
Q1
$78.9K Sell
30,694
-246
-0.8% -$601 ﹤0.01% 3228
2023
Q4
$63.1K Sell
30,940
-38,491
-55% -$70.3K ﹤0.01% 3206
2023
Q3
$119K Sell
69,431
-216
-0.3% -$383 ﹤0.01% 3083
2023
Q2
$136K Sell
69,647
-352
-0.5% -$824 ﹤0.01% 3125
2023
Q1
$195K Buy
69,999
+1,266
+2% +$3.62K ﹤0.01% 3060
2022
Q4
$237K Sell
68,733
-1,254
-2% -$3.58K ﹤0.01% 2896
2022
Q3
$180K Buy
69,987
+10,516
+18% +$33.5K ﹤0.01% 2983
2022
Q2
$144K Sell
59,471
-2,657
-4% -$6.98K ﹤0.01% 3091
2022
Q1
$256K Sell
62,128
-2,350
-4% -$12.4K ﹤0.01% 2977
2021
Q4
$829K Sell
64,478
-17,810
-22% -$197K ﹤0.01% 2258
2021
Q3
$889K Buy
82,288
+17,489
+27% +$159K ﹤0.01% 2189
2021
Q2
$592K Buy
64,799
+28,500
+79% +$264K ﹤0.01% 2484
2021
Q1
$342K Buy
+36,299
New +$500K ﹤0.01% 2708

Other funds holding GRTS

Stifel Financial's GRTS Position: Q2 2024 in Review

Stifel Financial sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 30,694 shares — an estimated $78.9K sold.

Stifel Financial first reported a position in GRTS in Q1 2021 and held it in 13 quarters. The position peaked at $889K in Q3 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Stifel Financial reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Stifel Financial sold 30,694 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $78.9K.
  • Stifel Financial first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Stifel Financial's Gritstone bio, Inc. Common Stock position peaked at $889K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Stifel Financial's 13F filing for Q2 2024, filed 13 Aug 2024.